rs12632456

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001457.4(FLNB):​c.4411G>A​(p.Val1471Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.312 in 1,613,678 control chromosomes in the GnomAD database, including 98,553 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1471L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.40 ( 14932 hom., cov: 32)
Exomes 𝑓: 0.30 ( 83621 hom. )

Consequence

FLNB
NM_001457.4 missense

Scores

1
6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.04

Publications

53 publications found
Variant links:
Genes affected
FLNB (HGNC:3755): (filamin B) This gene encodes a member of the filamin family. The encoded protein interacts with glycoprotein Ib alpha as part of the process to repair vascular injuries. The platelet glycoprotein Ib complex includes glycoprotein Ib alpha, and it binds the actin cytoskeleton. Mutations in this gene have been found in several conditions: atelosteogenesis type 1 and type 3; boomerang dysplasia; autosomal dominant Larsen syndrome; and spondylocarpotarsal synostosis syndrome. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Nov 2009]
FLNB Gene-Disease associations (from GenCC):
  • atelosteogenesis type I
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • atelosteogenesis type III
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Larsen syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • spondylocarpotarsal synostosis syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Boomerang dysplasia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.8902135E-7).
BP6
Variant 3-58132828-G-A is Benign according to our data. Variant chr3-58132828-G-A is described in ClinVar as Benign. ClinVar VariationId is 258114.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.95 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNBNM_001457.4 linkc.4411G>A p.Val1471Met missense_variant Exon 26 of 46 ENST00000295956.9 NP_001448.2
FLNBNM_001164317.2 linkc.4504G>A p.Val1502Met missense_variant Exon 27 of 47 NP_001157789.1
FLNBNM_001164318.2 linkc.4411G>A p.Val1471Met missense_variant Exon 26 of 46 NP_001157790.1
FLNBNM_001164319.2 linkc.4411G>A p.Val1471Met missense_variant Exon 26 of 45 NP_001157791.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNBENST00000295956.9 linkc.4411G>A p.Val1471Met missense_variant Exon 26 of 46 1 NM_001457.4 ENSP00000295956.5

Frequencies

GnomAD3 genomes
AF:
0.400
AC:
60724
AN:
151894
Hom.:
14908
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.589
Gnomad AMI
AF:
0.308
Gnomad AMR
AF:
0.455
Gnomad ASJ
AF:
0.246
Gnomad EAS
AF:
0.972
Gnomad SAS
AF:
0.548
Gnomad FIN
AF:
0.265
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.249
Gnomad OTH
AF:
0.392
GnomAD2 exomes
AF:
0.396
AC:
99624
AN:
251354
AF XY:
0.385
show subpopulations
Gnomad AFR exome
AF:
0.593
Gnomad AMR exome
AF:
0.546
Gnomad ASJ exome
AF:
0.243
Gnomad EAS exome
AF:
0.975
Gnomad FIN exome
AF:
0.263
Gnomad NFE exome
AF:
0.247
Gnomad OTH exome
AF:
0.321
GnomAD4 exome
AF:
0.303
AC:
442578
AN:
1461666
Hom.:
83621
Cov.:
36
AF XY:
0.305
AC XY:
222113
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.592
AC:
19819
AN:
33474
American (AMR)
AF:
0.532
AC:
23776
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.242
AC:
6332
AN:
26136
East Asian (EAS)
AF:
0.982
AC:
39001
AN:
39698
South Asian (SAS)
AF:
0.480
AC:
41406
AN:
86248
European-Finnish (FIN)
AF:
0.259
AC:
13840
AN:
53406
Middle Eastern (MID)
AF:
0.283
AC:
1631
AN:
5766
European-Non Finnish (NFE)
AF:
0.248
AC:
275954
AN:
1111828
Other (OTH)
AF:
0.345
AC:
20819
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
16774
33548
50321
67095
83869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9894
19788
29682
39576
49470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.400
AC:
60798
AN:
152012
Hom.:
14932
Cov.:
32
AF XY:
0.408
AC XY:
30331
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.589
AC:
24408
AN:
41418
American (AMR)
AF:
0.456
AC:
6963
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
852
AN:
3470
East Asian (EAS)
AF:
0.972
AC:
5033
AN:
5178
South Asian (SAS)
AF:
0.546
AC:
2629
AN:
4812
European-Finnish (FIN)
AF:
0.265
AC:
2799
AN:
10570
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.249
AC:
16921
AN:
67972
Other (OTH)
AF:
0.394
AC:
833
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1600
3199
4799
6398
7998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.302
Hom.:
33840
Bravo
AF:
0.423
TwinsUK
AF:
0.238
AC:
881
ALSPAC
AF:
0.255
AC:
981
ESP6500AA
AF:
0.584
AC:
2573
ESP6500EA
AF:
0.245
AC:
2109
ExAC
AF:
0.395
AC:
47961
Asia WGS
AF:
0.764
AC:
2655
AN:
3478
EpiCase
AF:
0.250
EpiControl
AF:
0.252

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 07, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

FLNB-Related Spectrum Disorders Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.82
.;D;.;.;.
Eigen
Benign
0.097
Eigen_PC
Benign
0.091
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.94
D;D;D;D;D
MetaRNN
Benign
8.9e-7
T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Uncertain
2.1
.;M;M;M;.
PhyloP100
3.0
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-2.2
N;N;N;N;N
REVEL
Uncertain
0.43
Sift
Benign
0.057
T;T;T;T;T
Sift4G
Uncertain
0.047
D;D;D;D;T
Polyphen
0.81, 0.88, 0.38
.;P;P;.;B
Vest4
0.19
MPC
0.62
ClinPred
0.037
T
GERP RS
2.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.16
gMVP
0.48
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12632456; hg19: chr3-58118555; COSMIC: COSV55871843; API